- Home
- NCMI vs PRME Comparison
NCMI vs PRME Comparison
Compare NCMI & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCMI
- PRME
- Stock Information
- Founded
- NCMI 2005
- PRME 2019
- Country
- NCMI United States
- PRME United States
- Employees
- NCMI N/A
- PRME N/A
- Industry
- NCMI Advertising
- PRME Medicinal Chemicals and Botanical Products
- Sector
- NCMI Consumer Discretionary
- PRME Health Care
- Exchange
- NCMI Nasdaq
- PRME Nasdaq
- Market Cap
- NCMI 476.2M
- PRME 191.7M
- IPO Year
- NCMI 2007
- PRME 2022
- Fundamental
- Price
- NCMI $4.89
- PRME $4.27
- Analyst Decision
- NCMI Strong Buy
- PRME Buy
- Analyst Count
- NCMI 5
- PRME 6
- Target Price
- NCMI $7.40
- PRME $9.38
- AVG Volume (30 Days)
- NCMI 633.9K
- PRME 5.0M
- Earning Date
- NCMI 08-04-2025
- PRME 08-04-2025
- Dividend Yield
- NCMI 2.47%
- PRME N/A
- EPS Growth
- NCMI N/A
- PRME N/A
- EPS
- NCMI N/A
- PRME N/A
- Revenue
- NCMI $238,300,000.00
- PRME $3,846,000.00
- Revenue This Year
- NCMI $10.10
- PRME $104.12
- Revenue Next Year
- NCMI $11.66
- PRME $108.24
- P/E Ratio
- NCMI N/A
- PRME N/A
- Revenue Growth
- NCMI 42.10
- PRME 550.76
- 52 Week Low
- NCMI $4.12
- PRME $1.11
- 52 Week High
- NCMI $7.60
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- NCMI 39.74
- PRME 80.29
- Support Level
- NCMI $4.57
- PRME $2.28
- Resistance Level
- NCMI $4.84
- PRME $4.83
- Average True Range (ATR)
- NCMI 0.16
- PRME 0.46
- MACD
- NCMI -0.02
- PRME 0.21
- Stochastic Oscillator
- NCMI 24.36
- PRME 84.52
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.